ANTENGENE-B (06996)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Lung Donald Andrew | 18-Jun-21 | FD | |||
| Chin John Francis | 18-Aug-20 | 01-Aug-24 | ED | ||
| John F. Chin | 01-Aug-24 | ED | Due to retirement | ||
| Chen Kan | 26-Mar-21 | 14-Jun-24 | Non-Executive Director | No reasons provided | |
| Qian Jing | 09-Nov-20 | 29-May-24 | INED | ||
| Alles Mark John | 02-Jan-20 | 14-Apr-23 | INED | ||
| Liu Yilun | 16-Dec-21 | 14-Apr-23 | Non-Executive Director | Due to his own business engagement which requires more of his attention and dedication | |
| Mark J. Alles | 14-Apr-23 | INED | In order to pursue other new opportunities taking an executive role within the pharmaceutical industry, which may or may not give rise to a potential conflict of interests | ||
| Lynch Kevin Patrick | 18-Jun-21 | 16-Dec-22 | ED | ||
| Dr. Kevin Patrick Lynch | 16-Dec-22 | ED | Due to retirement | ||
| Wong Keith Shing Cheung | 18-Aug-20 | 30-Mar-22 | CoSec | ||
| Keith Shing Cheung Wong | 30-Mar-22 | J-CoSec | Due to personal work adjustment | ||
| Cao Yanling | 04-Feb-19 | 16-Dec-21 | Non-Executive Director | ||
| Li Zhen | 04-Feb-19 | 18-Jun-21 | Non-Executive Director | ||
| Liu Yiteng | 22-Nov-18 | 18-Jun-21 | COO, ED | ||
| Hu Xubo | 22-Nov-18 | 26-Mar-21 | Non-Executive Director | ||
| Cao Yang | 18-Aug-20 | 15-Feb-21 | CoSec | ||
| Li Ming | 22-Nov-18 | 18-Aug-20 | Non-Executive Director | ||
| Li Teng | 22-Nov-18 | 18-Aug-20 | Non-Executive Director | ||
| Wong Wai Chiu | 30-Mar-22 | 09-Feb-15 | CoSec | ||
| Tang Sheng | 09-Nov-20 | 01-Jan-15 | INED | ||
| Fonseca Rafael | 14-Apr-23 | 26-Jun-12 | INED | ||
| Mei Jay | 28-Aug-18 | 13-May-05 | Ch | ||
| Mei Jay | 28-Aug-18 | 23-Feb-05 | CEO |